You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Clearing the Air in Cystic Fibrosis: Airway Clearance Approaches for Patients

  • Authors: Caralee J. Forseen, MD; Elliott Dasenbrook, MD, MHS
  • CME / ABIM MOC / CE Released: 4/18/2022
  • Valid for credit through: 4/18/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for pulmonologists, primary care physicians, nurses, nurse practitioners, physician assistants, and pharmacists.

The goal of this activity is that the learner will be better able to understand the latest advances in mucociliary clearance agents for airway clearance in patients with cystic fibrosis (CF) and data for practice integration, focusing on patient-centered treatment and quality of life. Healthcare providers (HCPs) need education to know how to translate data into practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Approaches for airway clearance in patients with CF
  • Have greater competence related to
    • Collaborating with the interprofessional team to optimize care for patients with CF
  • Demonstrate greater confidence in their ability to
    • Integrate advances in CF airway clearance into the management of patients with CF


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Caralee J. Forseen, MD

    Associate Professor of Medicine
    Director
    Adult Cystic Fibrosis Program
    Division of Pulmonary, Critical Care, and Sleep Medicine
    Medical College of Georgia at Augusta University
    Augusta, Georgia

    Disclosures

    Research funding from: Vertex Pharmaceuticals Incorporated

  • Elliott Dasenbrook, MD, MHS

    Director
    Adult Cystic Fibrosis Program and the Bronchiectasis Center
    Cleveland Clinic Respiratory Institute
    Cleveland, Ohio

    Disclosures

    Consultant or advisor for: Chiesi Pharmaceuticals, Inc.; Electromed; Hill-Rom; Insmed Incorporated; Vertex Pharmaceuticals Incorporated
    Speaker or member of speakers bureau for: Gilead; Insmed Incorporated; Lupin Pharmaceuticals, Inc.

Editor

  • Lisa Cockrell, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Lisa Cockrell, PhD, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-22-089-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Clearing the Air in Cystic Fibrosis: Airway Clearance Approaches for Patients

Authors: Caralee J. Forseen, MD; Elliott Dasenbrook, MD, MHSFaculty and Disclosures

CME / ABIM MOC / CE Released: 4/18/2022

Valid for credit through: 4/18/2023

processing....

Educational Impact Challenge

The goal of this activity is that the learner will be better able to understand the latest advances in mucociliary clearance agents for airway clearance in patients with cystic fibrosis (CF) and data for practice integration, focusing on patient-centered treatment and quality of life. Healthcare providers (HCPs) need education to know how to translate data into practice.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print